| __timestamp | CRISPR Therapeutics AG | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 17992000000 |
| Thursday, January 1, 2015 | 13403000 | 22400000000 |
| Friday, January 1, 2016 | 31056000 | 23910000000 |
| Sunday, January 1, 2017 | 35845000 | 23813000000 |
| Monday, January 1, 2018 | 48294000 | 24694000000 |
| Tuesday, January 1, 2019 | 63488000 | 23557000000 |
| Wednesday, January 1, 2020 | 88208000 | 25436000000 |
| Friday, January 1, 2021 | 102802000 | 24586000000 |
| Saturday, January 1, 2022 | 102464000 | 27295000000 |
| Sunday, January 1, 2023 | 76162000 | 34205000000 |
| Monday, January 1, 2024 | 72977000 | 28113000000 |
Unveiling the hidden dimensions of data
In the ever-evolving landscape of corporate finance, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Walgreens Boots Alliance, Inc., a stalwart in the retail pharmacy sector, and CRISPR Therapeutics AG, a pioneer in gene editing, offer a fascinating contrast. From 2014 to 2023, Walgreens consistently reported SG&A expenses exceeding $17 billion annually, peaking at $28 billion in 2024. This reflects its expansive global operations. In contrast, CRISPR Therapeutics, with its focus on innovation, saw a steady rise from $5 million in 2014 to over $100 million in 2021, before a slight dip in 2023. This 20-fold increase underscores its growth trajectory in the biotech arena. The data highlights the distinct operational scales and strategic priorities of these companies, offering insights into their financial stewardship and market positioning.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and CRISPR Therapeutics AG
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Who Optimizes SG&A Costs Better? Amgen Inc. or Walgreens Boots Alliance, Inc.
SG&A Efficiency Analysis: Comparing Gilead Sciences, Inc. and CRISPR Therapeutics AG
Breaking Down SG&A Expenses: Zoetis Inc. vs CRISPR Therapeutics AG
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Merus N.V.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?